Honokiol inhibited NF-κB activity and caused altered expression of many cell cycle and survival-associated proteins to confer its growth suppressive and chemosensitizing effects in pancreatic cancer cells. This evidence concerns the gene NFKB1 and familial pancreatic carcinoma.